Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
01/2009
01/14/2009CN101346378A Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
01/14/2009CN101346377A Aryl-isoxazol-4-yl-imidazoy1, 5-A pyridine derivatives
01/14/2009CN101346376A Polycyclic carbamoylpyridone derivative having inhibitory activity on HIV integrase
01/14/2009CN101346375A Compositions and methods for modulating gated ion channels
01/14/2009CN101346370A PDF inhibitors
01/14/2009CN101346358A Estrogen modulators
01/14/2009CN100451019C Oxysophocarpine and its salt preparing method
01/13/2009US7476746 PPAR active compounds
01/13/2009US7476688 Cyclic amidine derivatives
01/13/2009US7476676 Administering to the mammal an effective amount of a GSK-3 beta (glycogen synthase kinase-3 beta) to promote bone formation and treat bone metabolic diseases such as osteoporosis
01/13/2009US7476671 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
01/13/2009US7476666 HIV integrase inhibitors
01/13/2009US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
01/13/2009CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase
01/13/2009CA2237273C Angiogenesis inhibiting pyridazinamines
01/08/2009WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
01/08/2009WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors
01/08/2009WO2009006319A2 Ammosamides as anticancer agents
01/08/2009WO2009005729A1 Gamma secretase modulators
01/08/2009WO2009004914A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
01/08/2009WO2009004584A1 3-aza-bicyclo[3.3.0]octane compounds
01/08/2009WO2009004557A2 A process for the preparation of intermediates of tetracyclic compounds
01/08/2009WO2009004329A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors
01/08/2009WO2009003993A1 Piperidine derivatives useful as orexin receptor antagonists
01/08/2009WO2009003911A1 Thiophene-imidazopyridines
01/08/2009WO2009003669A2 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
01/08/2009WO2009003590A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
01/08/2009WO2008080001A3 Compounds and methods for kinase modulation, and indications therefor
01/08/2009US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists
01/08/2009US20090012103 Substituted heterocyclic compounds
01/08/2009US20090012093 Receptor Function Regulator
01/08/2009US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists
01/08/2009US20090012079 Triazolopyridine Compounds
01/08/2009US20090012078 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
01/08/2009US20090012077 Novel Compound - 827
01/08/2009US20090012076 Tyrosine kinase inhibitors
01/08/2009US20090012073 N-aroyl cyclic amines
01/08/2009US20090012035 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
01/08/2009US20090012034 Non-Nucleoside reverse transcriptase inhibitors
01/08/2009DE102007031220A1 Chinoide Verbindungen und deren Verwendung in halbleitenden Matrixmaterialien, elektronischen und optoelektronischen Bauelementen Quinoid compounds and their use in semi-conductive matrix materials, electronic and optoelectronic devices
01/08/2009CA2699965A1 Pet probe having an alkoxy group substituted by fluorine and hydroxy group
01/08/2009CA2693182A1 Compounds useful as raf kinase inhibitors
01/08/2009CA2692253A1 Gamma secretase modulators
01/08/2009CA2691638A1 Piperidine derivatives useful as orexin receptor antagonists
01/08/2009CA2691373A1 3-aza-bicyclo[3.3.0]octane compounds
01/08/2009CA2690679A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
01/07/2009EP2011498A1 Brain function-improving agent, and functional food containing the improving agent
01/07/2009EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials
01/07/2009EP2010531A1 Spirocyclic cyclohexane derivative with analgesic properties
01/07/2009EP2010530A2 Methods for the preparation of imidazole-containing compounds
01/07/2009EP2010529A1 Compositions and methods for modulating gated ion channels
01/07/2009EP2010527A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
01/07/2009EP2010525A2 Diketo-piperazine and piperidine derivatives as antiviral agents
01/07/2009EP2010521A1 Indazole compounds and methods for inhibition of cdc7
01/07/2009EP2010506A1 Diazepan derivatives modulators of chemokine receptors
01/07/2009EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
01/07/2009EP2010172A2 Indoles and benzoimidazoles as modulators of the histamine h4 receptor
01/07/2009EP1751155B1 Substituted azachinazolines having an antiviral action
01/07/2009EP1687318A4 New coupling agents for peptide synthesis
01/07/2009EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases
01/07/2009EP1204665B1 Chemokine receptor antagonists and methods of use therefor
01/07/2009CN101341138A Cyclic anilino-pyridinotriazines as GSK-3 inhibitors
01/07/2009CN101337961A Organic luminescent material amidine anthralin compounds, synthetic method and applications
01/07/2009CN101337960A Process for extracting matrine form Chinese traditional medicine extract
01/07/2009CN101337934A Method for preparing fluoroquinolone compound
01/07/2009CN101337928A Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins
01/07/2009CN100448874C N-aroyl cyclic amines
01/07/2009CN100448869C Anilinopyrazole derivatives useful for the treatment of diabetes
01/07/2009CN100448868C Tri-substituted heteroaryls and methods of making and using the same
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/06/2009US7473701 Substituted indazoles, compositions containing them, method of production and use
01/06/2009US7473696 CCR-2 antagonist salt
01/06/2009US7473694 excellent inhibitory activity against MAPKAP-K2; inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth; (4-ethoxyphenyl)(5-piperidin-3-yl-6,7-dihydro-5H-1,4,5,8a-tetraaza-s-indacen-8-yl)amine
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
01/06/2009CA2369504C Pyrazole compositions useful as inhibitors of erk
01/02/2009DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
01/02/2009DE102008028533A1 Verfahren zum Trocknen von Druckfarbe auf einem Bedruckstoff Method of drying printing ink on a printing material
01/01/2009US20090005566 Method for Making 1-Substituted 1H-Imidazo [4,5-C] Quinolin-4-Amine Compounds and Intermediates Therefor
01/01/2009US20090005565 Methods for one-pot n-demethylation/n-acylation of morphine and tropane alkaloids
01/01/2009US20090005546 Azo compound and method of preparing the azo compound
01/01/2009US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation
01/01/2009US20090005409 Pyrrolo[3,2-C] Pyrdine Derivatives and Processes for the Preparation Thereof
01/01/2009US20090005388 3-Heteroaryl-3,9-Diazabicyclo[3.3.1]Nonane Derivatives as Nicotinic Acetylcholine Receptor Agonists
01/01/2009US20090005379 Azaindole-2-Carboxamide Derivatives
01/01/2009US20090005377 Pyrazolopyridine Derivates
01/01/2009US20090005376 1-Alkoxy 1H-Imidazo Ring Systems and Methods
01/01/2009US20090005374 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
01/01/2009US20090005365 Therapeutic pyrazolonaphthyridine derivatives
01/01/2009US20090005356 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
12/2008
12/31/2008WO2009002807A2 Indolyl pyrrolidines for the treatment of cancer
12/31/2008WO2009002534A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
12/31/2008WO2009001129A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
12/31/2008WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors
12/31/2008WO2009001021A1 Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases
12/31/2008WO2009000832A2 Chemical compounds
12/31/2008WO2009000831A1 Bromine-substituted rylene tetracarboxylic acid derivatives, and the use thereof
12/31/2008WO2009000819A1 5-phenyl-1,3,4-oxadiazol-2-yl-acetyl-4-piperidinyl derivatives as cgrp receptor antagonists
12/31/2008WO2009000757A1 Piperazine compounds with herbicidal action
12/31/2008WO2009000745A1 Heterocyclic compounds for the treatment of tuberculosis
12/31/2008WO2009000663A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors